论文部分内容阅读
本文回顾了1971~1990年在我院治疗,并有较完整随访资料的376例涎腺肿瘤患者的治疗情况。发生在腮腺者261例,颌下腺37例,舌下腺4例,小涎腺74例。良性肿瘤162例,涎腺癌214例;涎腺癌的病理分型:癌在多形性腺瘤中52例,腺癌53例,粘液表皮样癌41例,腺泡细胞癌27例,乳头状囊腺癌11例,腺样囊性癌23例,鳞状细胞癌4例,未分化癌3例。214例涎腺癌5年生存率为69.6%,10年生存率为54.9%。良性肿瘤均手术治疗。182例涎腺癌采用手术或手术+术后放疗的治疗方案。手术是治疗涎腺肿瘤的首选方法。
This article reviews the treatment of 376 cases of parotid gland tumors treated in our hospital from 1971 to 1990 and with complete follow-up data. There were 261 cases of parotid glands, 37 cases of submandibular glands, 4 cases of sublingual glands and 74 cases of small parotid glands. 162 cases of benign tumors and 214 cases of parotid adenocarcinoma; pathological classification of adenocarcinoma: 52 cases of pleomorphic adenoma, 53 cases of adenocarcinoma, 41 cases of mucoepidermoid carcinoma, 27 cases of acinar cell carcinoma, papillary There were 11 cases of cystadenocarcinoma, 23 cases of adenoid cystic carcinoma, 4 cases of squamous cell carcinoma, and 3 cases of undifferentiated carcinoma. The 5-year survival rate of 214 cases of parotid gland cancer was 69.6%, and the 10-year survival rate was 54.9%. Benign tumors are treated surgically. 182 cases of salivary gland cancer were treated with surgery or surgery plus postoperative radiotherapy. Surgery is the preferred method for treating salivary gland tumors.